SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies

Analysing transcriptomic signatures and identifying potential genes for the protective effect of inactivated COVID-19 vaccines [PeerJ]

Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections

SARS-CoV-2 Delta and Omicron variants evade population antibody

RCSB PDB - 7YE5: SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs

Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections

Escape from neutralizing antibodies by SARS-CoV-2 spike protein

Frontiers Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study

Biosensors, Free Full-Text

Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections

SARS-CoV-2 Delta and Omicron variants evade population antibody

The spike glycoprotein of highly pathogenic human coronaviruses

LMB COVID-19 response - MRC Laboratory of Molecular Biology